https://www.europesays.com/ch/147903/ European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD) #ContinuousDelivery #EuropeanCommission #EuropeanUnion #MacularDegeneration #MacularEdema #ophthalmology #PortDeliveryPlatform #ranibizumab #Roche #Susvimo #TreatmentOptions #VisionLoss
#macularedema — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #macularedema, aggregated by home.social.